¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"RE"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
  • JrId: 6894
    JournalTitle: Renal physiology.
    MedAbbr: Ren Physiol
    ISSN: 0378-5858
    ESSN:
    IsoAbbr:
    NlmId: 7901911
  • JrId: 6895
    JournalTitle: Renal physiology and biochemistry.
    MedAbbr: Ren Physiol Biochem
    ISSN: 1011-6524
    ESSN:
    IsoAbbr:
    NlmId: 8906670
  • JrId: 6896
    JournalTitle: Rehabilitation record.
    MedAbbr: Rehabil Rec
    ISSN: 0034-3587
    ESSN:
    IsoAbbr:
    NlmId: 2985050
  • JrId: 6897
    JournalTitle: Sozialmedizin, physikalische Medizin, Praventivmedizin; internationale Zeitschrift mit Zentralblatt.
    MedAbbr: Rehabilitation (Bonn)
    ISSN: 0048-7147
    ESSN:
    IsoAbbr:
    NlmId: 1302716
  • JrId: 6898
    JournalTitle: Die Rehabilitation.
    MedAbbr: Rehabilitation (Stuttg)
    ISSN: 0034-3536
    ESSN:
    IsoAbbr:
    NlmId: 401273
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • N16.1*
    Renal tubulo-interstitial disorders in neoplastic diseases
    ½Å»ý¹° Áúȯ¿¡¼­ÀÇ ¼¼´¢°ü-»çÀÌÁú¼º Àå¾Ö
  • N16.8*
    Renal tubulo-interstitial disorders in other diseases classified elsewhere
    ´Þ¸® ºÐ·ùµÈ ±âŸ Áúȯ¿¡¼­ÀÇ ¼¼´¢°ü-»çÀÌÁú¼º Àå¾Ö
  • N16.4*
    Renal tubulo-interstitial disorders in systemic connective tissue disorders
    Àü½Å °áÇÕÁ¶Á÷ Àå¾Ö¿¡¼­ÀÇ ¼¼´¢°ü-»çÀÌÁú¼º Àå¾Ö
  • N16.5*
    Renal tubulo-interstitial disorders in transplant rejection)(T86.-
    ÀÌ½Ä °ÅºÎ¿¡¼­ÀÇ ¼¼´¢°ü-»çÀÌÁú¼º Àå¾Ö
  • I15.0
    Renovascular hypertenion
    ½ÅÇ÷°ü °íÇ÷¾Ð
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • rectocystotomy
    Á÷À广±¤Àý°³(¼ú), °ðâÀڹ汤Àý°³(¼ú)
  • rectofistula
    Á÷Àå»û±æ, °ðâÀÚ»û±æ, Á÷Àå·ç
  • rectogenital
    Á÷Àå»ý½Ä±â-, °ðâÀÚ»ý½Ä±â-
  • rectolabial
    Á÷ÀåÀ½¼ø-, °ðâÀÚÀ½¼ø-
  • rectolabial fistula
    Á÷ÀåÀ½¼ø´©°ø, °ðâÀÚÀ½¼ø»û±æ
  • rectoperineorrhaphy
    Á÷ÀåȸÀ½ºÀÇÕ(¼ú), °ðâÀÚ»ôºÀÇÕ(¼ú)
  • rectopexy
    Á÷Àå°íÁ¤(¼ú), °ðâÀÚ°íÁ¤(¼ú)
  • rectorectostomy
    Á÷ÀåÁ÷À忬°á(¼ú), °ðâÀÚ°ðâÀÚ¿¬°á(¼ú)
  • rectoromanoscope
    Á÷À屸ºÒ°áÀå°æ
  • rectoromanoscopy
    Á÷À屸ºÒ°áÀå°æ°Ë»ç(¹ý)
  • rectorrhaphy
    Á÷ÀåºÀÇÕ(¼ú), °ðâÀÚºÀÇÕ(¼ú)
  • rectoscope
    Á÷Àå°æ
  • rectoscopy
    Á÷Àå°æ°Ë»ç(¹ý)
  • rectosigmoid
    Á÷À屸ºÒ°áÀå-, °ðâÀÚ±¸ºÒâÀÚ-
  • rectosigmoidectomy
    Á÷À屸ºÒ°áÀåÀýÁ¦(¼ú), °ðâÀÚ±¸ºÒâÀÚÀýÁ¦(¼ú)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • relief incision
    ÀÌ¿ÏÀý°³
  • religious delusion
    Á¾±³¸Á»ó
  • religious problem
    Á¾±³¹®Á¦
  • relocation
    Àç¹èÄ¡, ÀçÀ§Ä¡
  • rem
    ·½
  • REM
    (¢¡rapid eye movement) ºü¸¥´«¿îµ¿, ±Þ¼Ó´«¿îµ¿
  • remaining tooth
    ÀÜÁ¸Ä¡¾Æ
  • remedy
    Ä¡·áÁ¦
  • remission
    ¿ÏÈ­
  • remittence
    ¿ÏÈ­
  • remnant
    ÀÜÀ¯¹°
  • remodeling
    ÀçÇü¼º
  • remodeling process
    ÀçÇü¼º°úÁ¤
  • remote
    ¸Õ-, ¿ø°Ý-
  • removability
    ÀýÁ¦°¡´É¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • rectal infusion
    °ðâÀÚÁÖÀÔ, Á÷ÀåÁÖÀÔ
  • rectal instillation
    °ðâÀÚ¹æ¿ïÁÖÀÔ, Á÷ÀåÁ¡ÀûÁÖÀÔ
  • rectal palpation
    Á÷Àå³»ÃËÁø, °ðâÀÚÃËÁø
  • rectal prolapse
    °ðâÀÚÅ»ÃâÁõ, Á÷ÀåÅ»ÃâÁõ
  • rectal reflex
    °ðâÀڹݻç, Á÷Àå¹Ý»ç
  • rectal shelf
    °ðâÀÚ¼±¹Ý, Á÷Àå¼±¹Ý
  • rectal sinus
    °ðâÀÚ±¼, Á÷Àå±¼
  • rectal suppository
    Ç×¹®Á¾à
  • rectal swab
    °ðâÀÚ¸éºÀäÃë¹ý, Á÷Àåµµ¸»¹ý
  • rectal urgency
    º¯¸øÂüÀ½, º¯Àý¹Ú(Áõ)
  • rectal valve
    °ðâÀÚÆÇ¸·, Á÷ÀåÆÇ¸·
  • rectal venous plexus
    °ðâÀÚÁ¤¸Æ¾ó±â
  • rectalgia
    (¢¡proctalgia) °ðâÀÚÅëÁõ, Á÷ÀåÅëÁõ
  • rectangular coordinate
    Á÷°¢ÁÂÇ¥
  • rectangular hyperbola
    Á÷°¢½Ö°î¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å.
  • recombinants
    ÀçÁ¶ÇÕÇü
  • recombination
    ÀçÁ¶ÇÕ.
  • recombination
    Àç°áÇÕ(î¢Ì¿ùê).
  • recombination correction
    Àç°áÇÕ±³Á¤
  • recombination fraction
    ÀçÁ¶Çպмö(î¢ðàùêÝÂâ¦)
  • recombination frequency
    ÀçÁ¶ÇÕºóµµ
  • recombination rate
    Àç°áÇÕ·ü(¡­ëÒ).
  • recombination value
    Àç°áÇÕ°ª.
  • recombination, gene
    À¯ÀüÀÚÀçÁ¶ÇÕ
  • recombination, high frequency (Hfr)
    °íºóµµÀçÁ¶ÇÕ
  • recombination, illegitimate
    ºñÁ¤±ÔÀçÁ¶ÇÕ
  • recombinational repair
    ÀçÁ¶ÇÕ(¼º) DNAº¹±¸
  • recommended dietary allowance
    À½½Ä¹°±ÇÀå·®.
  • recommended dietary allowance
    ¿µ¾ç±ÇÀå·®(ç½å×ÏèíáåÖ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • recessus caudalis ³ª
    ¸ï¸ûq¿ä, ÇÏÇÔ¿ä (ù»ùèèê).
  • recessus cochlearis ³ª
    ´ÞÆØÀÌÇÔ¿ä, ¿Í¿ìÇÔ¿ä(èÄéÚùèèê).
  • recessus costodiaphagmaticus ³ª
    ´Á°ñȾ°Ý¸·¿À¸ñ, ´Á°ñȾ°Ýµ¿(×ÎÍéüô̰÷Ó).
  • recessus costomediastinalis ³ª
    ´Á°ñÁ¾°Ý¿À¸ñ, ´Á°ñÁ¾°Ýµ¿(×ÎÍéðý̰÷Ó).
  • recessus cranialis ³ª
    ¸Ó¸®ÂÊ¿À¸ñ, »óÇÔ¿ä(ß¾ùèèê).
  • recessus duodenalis inferior ³ª
    ¾Æ·¡½ÊÀÌÁöÀå¿À¸ñ, ÇϽÊÀÌÁöÀåÇÔ¿ä(ù»ä¨ì£ ò¦ ùèèê).
  • recessus duodenalis superior ³ª
    À§½ÊÀÌÁöÀå¿À¸ñ, »ó½ÊÀÌÁöÀåÇÔ¿ä(ß¾ä¨ì£ò¦ ùèèê).
  • recessus duodenojejunalis ³ª
    ½ÊÀÌÁöÀå°øÀå¿À¸ñ, ½ÊÀÌÁöÀå°øÀå¿Í(ä¨ì£ò¦ Íö èÀ).
  • recessus duodenomesocolicus caudalis ³ª
    ¾Æ·¡½ÊÀÌÁöÀå°áÀå°£¸·¿À¸ñ ¸ï¸ù? , ÇϽÊÀÌÁöÀå°áÀå°£¸·ÇÔ¿ä(ù»ä¨ì£ò¦ Ì¿ ÊàØ¯ùèèê).
  • recessus duodenomesocolicus cranialis ³ª
    À§½ÊÀÌÁöÀå°áÀå°£¸·¿À¸ñ ¸Ó¸®ÂÊ , »ó½ÊÀÌÁöÀå°áÀå°£¸·ÇÔ¿ä(ß¾ä¨ì£ò¦íóÌ¿ íóÊàØ¯ùèèê).
  • recessus ellipticus ³ª
    Ÿ¿ø¿À¸ñ, Ÿ¿ø³¶ÇÔ¿ä(NCê­Ò¥ùèèê).
  • recessus epitympanicus ³ª
    °í½ÇÀ§¿À¸ñ, »ó °í½ÇÇÔ¿ä(ß¾ÍÕãøùèèê).
  • recessus frontalis ³ª
    ÀüµÎ¿À¸ñ, ÀüµÎÇÔ¿ä(îñÔéùèèê).
  • recessus hepatorenalis ³ª
    °£½ÅÀå¿À¸ñ, °£½ÅÇÔ¿ä(ÊÜãìùèèê).
  • recessus ileocecalis inferior ³ª
    ¾Æ·¡È¸Àå¸ÍÀå¿À¸ñ, ÇÏȸ¸ÍÇÔ¿ä(ù»üÞØîùèèê ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • replacement site
    ´ëÄ¡ ÀÚ¸®
  • replacement vector
    ´ëÄ¡ º¤ÅÍ
  • replica plating
    º¹Á¦(ÜÜð²) ±ò±â
  • replicase
    "¸®Çø®ÄÉÀ̽º, º¹Á¦È¿¼Ò(ÜÜð²ý£áÈ)"
  • replicating fork
    º¹Á¦(ÜÜð²) Æ÷Å©
  • replicating form
    º¹Á¦ Çü(úþ)
  • replicating unit
    º¹Á¦ ´ÜÀ§(Ó¤êÈ)
  • replication
    º¹Á¦(ÜÜð²)
  • replication bubble
    º¹Á¦ ¹öºí
  • replication eye
    º¹Á¦ ´«
  • replication fork
    º¹Á¦ Æ÷Å©
  • replication fragments
    º¹Á¦ Á¶°¢
  • replication order
    º¹Á¦ Â÷¼ö(ó­â¦)
  • replication origin
    º¹Á¦ ±âÁ¡(ÑÃïÃ)
  • replication polymerase
    º¹Á¦ Æú¸®¸Ó·¹À̽º
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • resorption fever
    Èí¼ö¿­
  • resorption of bone
    °ñÈí¼ö
  • respective
    °¢ÀÚÀÇ, °¢°¢ÀÇ, °³°³ÀÇ
  • respiration
    È£Èí
  • respiration rate
    È£Èí·ü
  • respirator
    ÀΰøÈ£Èí±â, È£Èí±â, È£Èí°è
  • respiratory
    È£Èí(¼º)ÀÇ
  • respiratory acidosis
    È£Èí¼º»êÁõ
  • respiratory alkalosis
    È£Èí¼º¾ËÄ®¸®Áò
  • respiratory arrest
    È£ÈíÁ¤Áö
  • respiratory bronchiole
    È£Èí±â°ü¼¼Áö, È£Èí¼º¼¼±â°üÁö
  • respiratory capacity
    È£Èí¿ë·®, ÆóȰ·®
  • respiratory center
    È£ÈíÁßÃß
  • respiratory dead space
    È£Èí¼º¹«È¿°ø°£
  • respiratory disease
    È£Èí±âº´, È£Èí°ï¶õ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • regenerating nociceptor
    Àç»ý Ä§ÇØ ¼ö¿ëü, Àç»ý À¯ÇØ ¼ö¿ë±â
  • regenerating primary afferent
    Àç»ý¼º ÀÏÂ÷ ±¸½É ½Å°æ
  • regeneration
    Àç»ý
    Á¶Á÷ ¼Õ»óÀ̳ª ±× ÀϺÎÀÇ ±¸Á¶°¡ ÀÚ¿¬Àû º¹¿ø, ¼Ò»ýÇÏ´Â °Í.
  • regenerative function
    Àç»ý ±â´É
  • regia auricularis
    ±Ó¹ÙÄû ºÎÀ§, À̰³ºÎ
  • regimen
    ¼·»ý¹ý, ¾ç»ý¹ý, Ä¡·á¹ý
    ¸ñÇ¥ ´Þ¼ºÀ» À§ÇÏ¿© ¸¸µé¾îÁø ½Ä»ç, ¿îµ¿ ±âŸÀÇ »ýȰ»óÀÇ ¾ö¹ÐÇÑ ±ÔÁ¦.
  • regio acromialis
    ¾î±ú µ¹±â ºÎÀ§, °ßºÀºÎ
  • regio buccalis
    º¼ ºÎÀ§, ÇùºÎ
  • regio celli anterior
    ¾Õ¸ñ ºÎÀ§, ¾ÕÂʸñ ºÎÀ§, Àü°æºÎ
  • regio clavicularis
    ¼â°ñ ºÎÀ§, ¼â°ñºÎ
  • regio coxae
    °ü°ñ ºÎÀ§, °ü°ñºÎ
  • regio epigastrica
    ¸íÄ¡ ºÎÀ§, »óÀ§ºÎ
  • regio infraorbitalis
    ¾È¿Í ¾Æ·¡ ºÎÀ§, ¾È¿Í ÇϺÎ
  • regio labialis mandibularis
    ÇϾǰñºÎ
  • regio laryngica
    ÈĵΠºÎÀ§, ÈĵκÎ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
receptors, leukocyte-adhesion Family of proteins associated with the capacity of leukocytes, including lymphocytes, monocytes, and neutrophils, to adhere to each other and to certain substrata, e.g., the c3bi component of complement. Members of this family are the lymphocyte function-associated antigen-1 (lfa-1), the macrophage-1 antigen (mac-1), and the antigen p150,95 or p150,95 leukocyte adhesion protein. They all share a common beta-subunit which is the CD18 antigen. All three of the above antigens are absent in inherited leukocyte-adhesion deficiency syndrome, which is characterised by recurrent bacterial infections, impaired pus formation, and wound healing as well as abnormalities in a wide spectrum of adherence-dependent functions of granulocytes, monocytes, and lymphoid cells.
(12 Dec 1998)
receptors, leukotriene Cell-surface receptors that bind leukotrienes with high affinity and trigger intracellular changes influencing the behaviour of cells. The leukotriene receptor subtypes have been tentatively named according to their affinities for the endogenous leukotrienes ltb4, ltc4, ltd4, and lte4.
(12 Dec 1998)
receptors, leukotriene b4 A class of cell surface leukotriene receptors with a preference for leukotriene b4. Leukotriene b4 receptor activation influences chemotaxis, chemokinesis, adherence, enzyme release, oxidative bursts, and degranulation in polymorphonuclear leukocytes. There are at least two subtypes of these receptors. Some actions are mediated through the inositol phosphate and diacylglycerol second messenger systems.
(12 Dec 1998)
receptors, lh Those protein complexes or molecular sites on the surfaces and cytoplasm of gonadal cells that bind luteinizing or chorionic gonadotropic hormones and thereby cause the gonadal cells to synthesise and secrete sex steroids. The hormone-receptor complex is internalised from the plasma membrane and initiates steroid synthesis.
(12 Dec 1998)
receptors, lhrh Receptors with a 6-kD protein on the surfaces of cells that secrete lh or fsh, usually in the adenohypophysis. Lhrh binds to these receptors, is endocytosed with the receptor and, in the cell, triggers the release of lh or fsh by the cell. These receptors are also found in rat gonads. Inhibin prevents the binding of gnrh to its receptors.
(12 Dec 1998)
receptors, lipoprotein Cell surface proteins that bind lipoproteins with high affinity. Lipoprotein receptors in the liver and peripheral tissues mediate the regulation of plasma and cellular cholesterol metabolism and concentration. The receptors generally recognise the apolipoproteins of the lipoprotein complex, and binding is often a trigger for endocytosis.
(12 Dec 1998)
receptors, lymphocyte homing Cell surface glycoproteins on lymphocytes and other leukocytes that mediate adhesion to specialised blood vessels called high endothelial venules. Several different classes of lymphocyte homing receptors have been identified, and they appear to target different surface molecules (addressins) on high endothelial venules in different tissues. The adhesion plays a crucial role in the trafficking of lymphocytes.
(12 Dec 1998)
receptors, macrophage colony-stimulating factor Glycoproteins of mw 165 kD which are encoded by the c-fms proto-oncogene. The binding of csf-1 to its receptors activates an intrinsic tyrosine kinase activity resulting in autophosphorylation of the receptors on tyrosine, rapid receptor down-regulation, and phosphorylation of as yet unidentified physiologic substrates that initiate a mitogenic response.
(12 Dec 1998)
receptors, metabotropic glutamate Cell surface proteins that bind glutamate and act through g-proteins to influence second messenger systems. Several types of metabotropic glutamate receptors have been cloned. They differ in pharmacology, distribution, and mechanisms of action.
(12 Dec 1998)
receptors, mineralocorticoid Cytoplasmic proteins that specifically bind mineralocorticoids and mediate their cellular effects. The receptor with its bound ligand acts in the nucleus to induce transcription of specific segments of DNA. Mineralocorticoids were named for their actions on extracellular electrolyte concentrations. The most important example is aldosterone.
(12 Dec 1998)
receptors, mitogen Glycoprotein molecules on the surface of b- and T-lymphocytes, that react with molecules of antilymphocyte sera, lectins, and other agents which induce blast transformation of lymphocytes.
(12 Dec 1998)
receptors, muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for muscarine over nicotine. There are several subtypes (usually m1, m2, m3...) that are characterised by their cellular actions, pharmacology, and molecular biology.
(12 Dec 1998)
receptors, n-methyl-d-aspartate A class of ionotropic glutamate receptors characterised by affinity for n-methyl-d-aspartate. Nmda receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity.
(12 Dec 1998)
receptors, nerve growth factor Cell surface receptors that bind nerve growth factor (ngf) and trigger intracellular changes influencing the behaviour of cells. Nerve growth factor receptors mediate the effects of nerve growth factor on the survival and growth of neurons.
(12 Dec 1998)
receptors, neurokinin-1 A class of cell surface receptors for tachykinins with a preference for substance p. Neurokinin-1 (nk-1) receptors have been cloned and are members of the G-protein coupled receptor superfamily. They are found on many cell types including central and peripheral neurons, smooth muscle cells, acinar cells, endothelial cells, fibroblasts, and immune cells.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 16
  • Receptor, Nerve Growth Factor - »õâ A low affinity receptor that binds NERVE GROWTH FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; and neurotrophin 4.
    Synonyms : GP80-LNGFR, Neurotrophin Receptor p75, Neurotropin Receptor p75, gp75 NGFR, p75 Neurotrophin Receptor, GP80 LNGFR, NGFR, gp75, Nerve Growth Factor Receptor, Low Affinity, Neurotrophin Receptor, p75, Receptor p75, Neurotrophin, Receptor p75, Neurotropin
  • Receptor, Notch1 - »õâ A notch receptor that interacts with a variety of ligands and regulates SIGNAL TRANSDUCTION PATHWAYS for multiple cellular processes. It is widely expressed during EMBRYOGENESIS and is essential for EMBRYONIC DEVELOPMENT.
    Synonyms : Notch1 Protein
  • Receptor, Notch2 - »õâ A notch receptor that plays an important role in CELL DIFFERENTIATION in a variety of cell types. It is the preferentially expressed notch receptor in mature B-LYMPHOCYTES.
    Synonyms : Notch2 Protein
  • Receptor, PAR-1 - »õâ A thrombin receptor subtype that couples to HETEROTRIMERIC GTP-BINDING PROTEINS resulting in the activation of a variety of signaling mechanisms including decreased intracellular CYCLIC AMP, increased PHOSPHOLIPASE C and increased PHOSPHOLIPASE A2.
    Synonyms : PAR1 Receptor, Proteinase-Activated Receptor 1, PAR 1 Receptor, Protease Activated Receptor 1, Proteinase Activated Receptor 1, Receptor, PAR 1, Receptor, PAR1
  • Receptor, PAR-2 - »õâ A G-protein-coupled, proteinase-activated receptor that is expressed in a variety of tissues including ENDOTHELIUM; LEUKOCYTES; and the GASTROINTESTINAL TRACT. The receptor is activated by TRYPSIN, which cleaves off the N-terminal peptide from the receptor. The new N-terminal peptide is a cryptic ligand for the receptor. The uncleaved receptor can also be activated by the N-terminal peptide present on the activated THROMBIN RECEPTOR and by small synthetic peptides that contain the unmasked N-terminal sequence.
    Synonyms : PAR2 Receptor, Protease-Activated Receptor 2, Receptor, Trypsin, Trypsin Receptor, Trypsin Receptors, PAR 2 Receptor, Protease Activated Receptor 2, Receptor 2, Protease-Activated, Receptor, PAR 2, Receptor, PAR2, Receptors, Trypsin
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
·¹¹Ì´ÒÁ¤8mg - »õâ
Janssen-Cilag
E02170391 Galantamine hydrobromide
Àü¹®ÀǾàǰ | »èÁ¦
¸®½ºÅ²°Ö - »õâ
º¸·ÉÁ¦¾à
A09305311 Amikacin Sulfate
ÀϹÝÀǾàǰ | ±Þ¿©
·¹Å䳪Á¦Á¤ - »õâ
À§´õ½º¸ÞµðÆÊ
A03702451 Streptodornase, Streptokinase
Àü¹®ÀǾàǰ | ±Þ¿©
Á߿ܷ¹´ÏÅØÁ¤5mg - »õâ
Áß¿Ü
A02104891 Enalapril maleate
Àü¹®ÀǾàǰ | »èÁ¦
·¹³ªÁ©Á¤400 - »õâ
Á¦Àϱ⸰¾àǰ
E00820091 Sevelamer HCl
Àü¹®ÀǾàǰ | ±Þ¿©
¸®Æä¹Î¿¡ÇÁÁ¤ - »õâ
±¹Á¦¾àǰ°ø¾÷
Cimicifuga fluid extract, Hyperici 80% methanol dried extract
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¸®·¢Ä¡¿Àݼ¿ - »õâ
ÇìÆÄ°¡µå
A57050411 Thiocolchicoside
Àü¹®ÀǾàǰ | »èÁ¦
·¹³ªÅæÁ¤20mg - »õâ
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à
A12903341 Enalapril maleate
Àü¹®ÀǾàǰ | »èÁ¦
¸®Æä¾î°Ö - »õâ
¿µÀÏÁ¦¾à
A16652371 Policresulen 50% solution
ÀϹÝÀǾàǰ | »èÁ¦
·¹Äڹ̵åÁ¤ - »õâ
À¯ÇѾçÇà
A04506451 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
reinforcement support: a military operation (often involving new supplies of men and materiel) to strengthen a military force or aid in the performance of its mission; "they called for artillery support" information that makes more forcible or convincing; "his gestures provided eloquent reinforcement for his complaints" reinforcing stimulus: (psychology) a stimulus that strengthens or weakens the behavior that produced it strengthener: a device designed to provide additional strength; "the cardboard backing was just a strengthener"; "he used gummed reinforcements to hold the page in his notebook" reward: an act performed to strengthen approved behavior
Ãâó: wordnet.princeton.edu/perl/webwn
resistant immune: relating to or conferring immunity (to disease or infection) tolerant: able to tolerate environmental conditions or physiological stress; "the plant is tolerant of saltwater"; "these fish are quite tolerant as long as extremes of pH are avoided"; "the new hybrid is more resistant to drought" impervious to being affected; "resistant to the effects of heat"; "resistant to persuasion" insubordinate: disposed to or engaged in defiance of established authority repellent: incapable of absorbing or mixing with; "a water-repellent fabric"; "plastic highly resistant to steam and water"
Ãâó: wordnet.princeton.edu/perl/webwn
rectified having been put right
Ãâó: wordnet.princeton.edu/perl/webwn
refractory anemia any of various anemic conditions that are not successfully treated by any means other than blood transfusions (and that are not associated with another primary disease)
Ãâó: wordnet.princeton.edu/perl/webwn
recapitulation palingenesis: emergence during embryonic development of various characters or structures that appeared during the evolutionary history of the strain or species (music) the section of a composition or movement (especially in sonata form) in which musical themes that were introduced earlier are repeated a summary at the end that repeats the substance of a longer discussion
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • rear admiral
    ÇØ±º ¼ÒÀå
  • rear end
    ÈĺÎ;ÈĹÌ;±ÃµÕÀÌ
  • rear guard
    ÈÄÀ§;(Á¤´çµîÀÇ)º¸¼öÆÄ
  • rear light(lamp)
    (ÀÚµ¿Â÷ÀÇ)¹Ìµî
  • rear mirror
    =REARVIEW MIRROR
  • rear rank
    ÈÄ¿­
  • rear sight
    µÞ°¡´ÆÀÚ(ÃÑÀÇ)
  • rear vassal
    ¹è½Å;°¡½Å
  • rear-end
    ÈĺÎÀÇ;ÈĹÌÀÇ
  • rear-guard action
    Áö¿¬ ÀÛÀü;¼ÓÀÌ´Â(µûµ¹¸®´Â)Çൿ(Àü¼ú) V
  • rear-vision mirror
    =REARVIEW MIRROR
  • rear-wheel drive
    (ÀÚµ¿Â÷ÀÇ)µÞ¹ÙÄû ±¼¸²;ÈÄ·û±¸µ¿
  • rearer
    ¾çÀ°ÀÚ;»çÀ°ÀÚ;Àç¹èÀÚ;µÞ´Ù¸®·Î ¼­´Â ¹ö¸©ÀÌ ÀÖ´Â ¸»
  • rearm
    À籺ºñ½ÃŰ´Ù
  • rearm
    À繫Àå½ÃŰ´Ù;½Å¹«±â¸¦ °®Ãß°ÔÇÏ´Ù;À繫Àå(À籺ºñ)ÇÏ´Ù
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 16
RE an immunoglobulin E that is formed as an antibody against allergens (such as pollen)
RE an old small silver Spanish coin
RE any rational or irrational number
RE possible to be treated as fact
RE having substance or capable of being treated as fact
RE not synthetic or spurious
RE being or occurring in fact or actuality
RE no less than what is stated
RE (economics) being value measured in terms of purchasing power
RE founded on practical matters
RE coinciding with reality
RE not to be taken lightly
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 16
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á